BCL2 and gastric cancer: Increased levels of Bcl-2 expression have been also associated with resistance to different drugs including 5-fluorouracil in gastric cancer [23] cisplatin in ovarian cancer [24] and doxorubicin in osteosarcoma and chondrosarcoma [25,26].